Epidermal p65/NF-κB signalling is essential for skin carcinogenesis

EMBO Mol Med. 2014 Jul;6(7):970-83. doi: 10.15252/emmm.201303541.

Abstract

The nuclear factor kappa B (NF-κB) signalling pathway exhibits both tumour-promoting and tumour-suppressing functions in different tissues and models of carcinogenesis. In particular in epidermal keratinocytes, NF-κB signalling was reported to exert primarily growth inhibitory and tumour-suppressing functions. Here, we show that mice with keratinocyte-restricted p65/RelA deficiency were resistant to 7, 12-dimethylbenz(a)anthracene (DMBA)-/12-O-tetra decanoylphorbol-13 acetate (TPA)-induced skin carcinogenesis. p65 deficiency sensitized epidermal keratinocytes to DNA damage-induced death in vivo and in vitro, suggesting that inhibition of p65-dependent prosurvival functions prevented tumour initiation by facilitating the elimination of cells carrying damaged DNA. In addition, lack of p65 strongly inhibited TPA-induced epidermal hyperplasia and skin inflammation by suppressing the expression of proinflammatory cytokines and chemokines by epidermal keratinocytes. Therefore, p65-dependent NF-κB signalling in keratinocytes promotes DMBA-/TPA-induced skin carcinogenesis by protecting keratinocytes from DNA damage-induced death and facilitating the establishment of a tumour-nurturing proinflammatory microenvironment.

Keywords: NF‐κB signalling; apoptosis; inflammation; mouse models of cancer; skin carcinogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 9,10-Dimethyl-1,2-benzanthracene
  • Animals
  • Carcinogenesis / chemically induced
  • Carcinogenesis / genetics
  • Carcinogenesis / immunology*
  • Carcinogenesis / pathology
  • Gene Deletion
  • Keratinocytes / immunology
  • Keratinocytes / pathology
  • Mice
  • NF-kappa B / immunology*
  • Signal Transduction*
  • Skin / immunology
  • Skin / metabolism
  • Skin / pathology*
  • Skin Neoplasms / chemically induced
  • Skin Neoplasms / genetics
  • Skin Neoplasms / immunology*
  • Skin Neoplasms / pathology
  • Transcription Factor RelA / genetics
  • Transcription Factor RelA / immunology*

Substances

  • NF-kappa B
  • Rela protein, mouse
  • Transcription Factor RelA
  • 9,10-Dimethyl-1,2-benzanthracene